Skip to main content

Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
02/02/2022
In this week's edition of Talking Therapeutics, Dr Jennings reviews data regarding the appropriate and safe use of dronedarone in patients who received atrial fibrillation ablation.
In this week's edition of Talking Therapeutics, Dr Jennings reviews data regarding the appropriate and safe use of dronedarone in patients who received atrial fibrillation ablation.
In this week's edition of...
02/02/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
02/16/2022
In the newest installment of Talking Therapeutics, Dr Jennings highlights extended post-procedure anticoagulation, as well as new research on acetaminophen's impact on blood pressure.
In the newest installment of Talking Therapeutics, Dr Jennings highlights extended post-procedure anticoagulation, as well as new research on acetaminophen's impact on blood pressure.
In the newest installment of...
02/16/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
08/01/2023
Dr Jennings discusses research showing a combination of rosuvastatin and ezetimibe could decrease the incidence of major adverse cardiovascular events in patients with atherosclerotic cardiovascular disease who received percutaneous coronary...
Dr Jennings discusses research showing a combination of rosuvastatin and ezetimibe could decrease the incidence of major adverse cardiovascular events in patients with atherosclerotic cardiovascular disease who received percutaneous coronary...
Dr Jennings discusses research...
08/01/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
02/02/2023
In this week's installment of Talking Therapeutics, Dr Jennings discusses a study comparing the efficacy of 2 loop diuretics for patients with heart failure.
In this week's installment of Talking Therapeutics, Dr Jennings discusses a study comparing the efficacy of 2 loop diuretics for patients with heart failure.
In this week's installment of...
02/02/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/01/2021
Reviewing the latest science from major medical meetings has become a recurring theme of Talking Therapeutics. This week, Dr Jennings reviews research presented at the European Society of Cardiology meeting.
Reviewing the latest science from major medical meetings has become a recurring theme of Talking Therapeutics. This week, Dr Jennings reviews research presented at the European Society of Cardiology meeting.
Reviewing the latest science...
09/01/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
04/28/2022
Dr Jennings explores a new recommendation by the US Preventive Services Task Force to reduce aspirin use for the prevention of cardiovascular disease.
Dr Jennings explores a new recommendation by the US Preventive Services Task Force to reduce aspirin use for the prevention of cardiovascular disease.
Dr Jennings explores a new...
04/28/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
12/01/2022
Dr Jennings shares findings from a new study evaluating RAAS inhibitors for the treatment of advanced chronic kidney disease.
Dr Jennings shares findings from a new study evaluating RAAS inhibitors for the treatment of advanced chronic kidney disease.
Dr Jennings shares findings from...
12/01/2022
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
01/02/2024
In the latest installment of Talking Therapeutics, Dr Jennings explores research that redefines the way health care professionals should approach treatment for patients with heart failure.
In the latest installment of Talking Therapeutics, Dr Jennings explores research that redefines the way health care professionals should approach treatment for patients with heart failure.
In the latest installment of...
01/02/2024
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
11/24/2021
Dr Jennings highlights research on dietary- and medication-related factors contributing to resistant hypertension in this week's Talking Therapeutics.
Dr Jennings highlights research on dietary- and medication-related factors contributing to resistant hypertension in this week's Talking Therapeutics.
Dr Jennings highlights research...
11/24/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
07/21/2022
In the face of an impending shortage, Dr Jennings explores alternative options to dobutamine for treating cardiogenic shock.
In the face of an impending shortage, Dr Jennings explores alternative options to dobutamine for treating cardiogenic shock.
In the face of an impending...
07/21/2022
Pharmacy Learning Network